ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1168

Barriers to Effectiveness of Non-surgical Treatments for Knee Osteoarthritis in a Diverse Racial/Ethnic Population: A Nominal Group Qualitative Study

Jasvinder Singh, University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2021

Keywords: barriers, Disparities, Osteoarthritis, Patient reported outcomes, treatment effectiveness

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster III: Patient Preferences (1153–1169)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Knee osteoarthritis (OA) has worse outcome in racial/ethnic minorities, who also have more severe pain, disability and worse outcomes. However, most qualitative studies include primarily Caucasian people with knee OA. Therefore, our objective was to examine patient experience, views and opinions of reasons for why the current knee OA treatments are not working for them in a diverse racial/ethnic group of people.

Methods: Nominal groups were conducted with consecutive clinic patients with knee OA at a medical center, oversampling African Americans. Patients discussed and rank-ordered their concerns.

Results: Fourteen nominal groups with 48 knee OA patients were conducted with mean age, 60.6 years (standard deviation, 9.8) and knee OA duration, 7.8 years (sd, 5.4); 25% were men, and 46% were African American. The most frequently cited highly-ranked concerns, divided into 3 categories as follows:

A. Medication-related: (1) side effects (9 groups); (2) limited efficacy (9 groups); (3) medication not targeting underlying disease; (4) lack of personalized medication use; and (5) temporary benefit;

B. Exercise/Physical therapy related: (1) exacerbation of joint pain (8 groups); (2) difficulty in doing exercises (6 groups); (3) lack of motivation (8 groups); (4) technical challenges/lack of personalized exercise regimens (1 group); (5) cost (3 groups); and

C. Weight loss related (1) difficulty in achieving weight loss (7 groups); (2) motivation (2 groups); and (3) limited efficacy for symptom improvement (1 group).

Conclusion: Participants with knee osteoarthritis, consisting of a diverse racial/ethnic representation, identified several barriers to the effectiveness of current knee OA treatments. This new knowledge provides insights for making the current treatment options potentially more usable and/or more effective. Given the significant consequences of knee OA, limited/no disease-modifying drugs this strategy can potentially improve clinical care and patient outcomes.


Disclosures: J. Singh, Crealta/Horizon, 2, Medisys, 2, Fidia, 2, PK Med, 2, Two labs Inc, 2, Adept Field Solutions, 2, Clinical Care options, 2, Clearview healthcare partners, 2, Putnam associates, 2, Focus forward, 2, Navigant consulting, 2, Spherix, 2, MedIQ, 2, Jupiter Life Science, 2, UBM LLC, 2, Trio Health, 2, Medscape, 2, WebMD, 2, Practice Point communications, 2, the National Institutes of Health, 2, the American College of Rheumatology, 2, TPT Global Tech, 11, Vaxart pharmaceuticals, 11, Charlotte’s Web Holdings, Inc., 11, Amarin pharmaceuticals, 11, Viking pharmaceuticals, 11, Moderna pharmaceuticals, 11, speaker’s bureau of Simply Speaking, 6, member of the executive of Outcomes Measures in Rheumatology, 4.

To cite this abstract in AMA style:

Singh J. Barriers to Effectiveness of Non-surgical Treatments for Knee Osteoarthritis in a Diverse Racial/Ethnic Population: A Nominal Group Qualitative Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/barriers-to-effectiveness-of-non-surgical-treatments-for-knee-osteoarthritis-in-a-diverse-racial-ethnic-population-a-nominal-group-qualitative-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/barriers-to-effectiveness-of-non-surgical-treatments-for-knee-osteoarthritis-in-a-diverse-racial-ethnic-population-a-nominal-group-qualitative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology